Hydromorphone is an opioid analgesic used to treat moderate to severe pain when the use of an opioid is indicated.
Topic |
---|
|
|
All by date | | Start date | Site | Title |
---|
NL-24-0349, Units 1 and 2 - 10 CFR 26.719(c)(1) 30-Day Report Blind Performance Test Results Inconsistent with Sample Provided | 20 September 2024 | Farley | Units 1 and 2 - 10 CFR 26.719(c)(1) 30-Day Report Blind Performance Test Results Inconsistent with Sample Provided | ENS 57291 | 26 August 2024 17:00:00 | Farley | False Negative Indicated on a Fitness for Duty Blind Quality Assurance Test | ML24185A212 | 11 July 2024 | | 10 CFR Part 26 Fitness for Duty Program Updates, NEI Access Authorization-Fitness for Duty Workshop July 2024 | ML24152A151 | 4 June 2024 | | Presentation to the Drug Testing Advisory Board (Hhs/Samhsa), Performance Trends and Program Updates, Fitness for Duty (FFD) Programs, 10 CFR Part 26, June 4, 2024 - Slides | ML23181A098 | 12 July 2023 | | NRC Presentation on the November 2022, 10 CFR Part 26 Final Rule - NEI Access Authorization-Fitness for Duty Workshop July 2023 | ML23181A096 | 11 July 2023 | | NRC Presentation to FFD Program Managers and Auditors on 10 CFR Part 26 Final Rule - NEI Access Authorization-Fitness for Duty Workshop July 2023 | ML23181A095 | 10 July 2023 | | NRC Presentation to Medical Review Officers on 10 CFR Part 26 Final Rule - NEI Access Authorization-Fitness for Duty Workshop July 2023 | ML23163A252 | 13 June 2023 | | Presentation to the Drug Testing Advisory Board on NRC 10 CFR Part 26 Fitness for Duty Program, June 13, 2023 | ML23067A087 | 7 March 2023 | | Presentation to the Drug Testing Advisory Board on NRC 10 CFR Part 26 Fitness for Duty Program Updates, March 7, 2023 | ML21111A036 | 5 December 2022 | | STC-22-066 Rulemaking Final Rule: Fitness for Duty Drug Testing Requirements, 10 CFR Part 26 |
|
---|